Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an Asia-Pacific Task Force

HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance

(2013) W. Q. Sheng et al.   ANNALS OF ONCOLOGY

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population

(2013) Ling Shan et al.   Diagnostic Pathology

Gastric HER2 Testing Study (GaTHER)

(2012) Stephen B. Fox et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

(2012) V. S. Warneke et al.   ANNALS OF ONCOLOGY

A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages

(2012) Junhun Cho et al.   ANNALS OF SURGICAL ONCOLOGY

Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas

(2012) H. H. Yoon et al.   CLINICAL CANCER RESEARCH

Clinical significance of intratumoral HER2 heterogeneity in gastric cancer

(2012) Hee Eun Lee et al.   EUROPEAN JOURNAL OF CANCER

HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

(2012) Carlos Gómez-Martin et al.   JOURNAL OF CLINICAL PATHOLOGY

Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues

(2012) V. M. Neumeister et al.   JNCI-Journal of the National Cancer Institute

The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor and HER2 expression in invasive breast carcinoma

(2012) Isil Z Yildiz-Aktas et al.   MODERN PATHOLOGY

Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas

(2012) Eun Yoon Cho et al.   MODERN PATHOLOGY

HER2 testing in gastric cancer: a practical approach

(2012) Josef Rüschoff et al.   MODERN PATHOLOGY

Evaluation of HER2 Protein Expression in Gastric Carcinomas: Comparative Analysis of 1414 Cases of Whole-Tissue Sections and 595 Cases of Tissue Microarrays

(2011) Kab Choong Kim et al.   ANNALS OF SURGICAL ONCOLOGY

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

(2011) Carlos Gómez-Martín et al.   Clinical & Translational Oncology

Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma

(2011) Min A Kim et al.   HISTOPATHOLOGY

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

(2011) J. M. S. Bartlett et al.   JOURNAL OF CLINICAL PATHOLOGY

Quality assessment of HER2 testing by monitoring of positivity rates

(2011) Harald Choritz et al.   VIRCHOWS ARCHIV

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

(2010) Josef Rüschoff et al.   VIRCHOWS ARCHIV

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY